Cancer Research UK on Path to Building National Genetic Testing Service
February 16, 2011
Cancer Research UK on Path to Building National Genetic Testing Service
By bringing together hospitals and genetic testing labs, Cancer Research UK is hoping to develop an improved model for genetically testing patients' tumors, which could be scaled up for use in the UK's National Health Service.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Resuscitation Uncertain: Can Debiopharm Help Revive Pfizer's Failed Melanoma Drug?
April 28, 2010 / Pharmacogenomics Reporter - With New Hires to Pharma Business Development Team, Qiagen Prioritizes Rx/Dx Partnership Strategy
April 21, 2010 / Pharmacogenomics Reporter - Lab21 Offering Companion Testing to Personalize ALK Inhibitors for NSCLC Patients
February 22, 2012 / Pharmacogenomics Reporter - MDxHealth Nets Methylation Biomarker Deal with Pfizer, Partners for PARP Inhibitor
February 2, 2011 / Pharmacogenomics Reporter - Despite PGx Leads, Avastin Access Debate Not Focused on Personalized Medicine Strategies
August 25, 2010 / Pharmacogenomics Reporter